Pfizer’s Newest Vaccine Plant Has Persistent Mold Issues and a History of Recalls
Tampa Bay Times by Sarah Jane Tribble
McPherson, KS – Pfizer’s management knew last year there was “a mold issue” at the Kansas facility now slated to produce the drugmaker’s urgently needed COVID-19 vaccine, according to a Food and Drug Administration inspection report. The McPherson, Kansas, facility, which FDA inspectors wrote is the nation’s largest manufacturer of sterile injectable controlled substances, has a long, troubled history. Nearly a decade’s worth of FDA inspection reports, recalls and reprimands reviewed by KHN show the facility as a repeat offender. FDA investigators have repeatedly noted in reports that the plant has failed to control quality and contamination or fully investigate after production failures.